Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes

Author:

Poli Daniela,Falsini Matteo,Varano Flavia,Betti Marco,Varani Katia,Vincenzi Fabrizio,Pugliese Anna Maria,Pedata Felicita,Dal Ben Diego,Thomas Ajiroghene,Palchetti Ilaria,Bettazzi Francesca,Catarzi Daniela,Colotta Vittoria

Funder

University of Florence

Italian Ministry for University and Research

Ente Cassa di Risparmio di Firenze

University of Camerino, Italy

Italian Ministry for University and Research, Rome, Italy

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference63 articles.

1. International union of Pharmacology LXXXI. Nomenclature and classification of adenosine receptors. An up date;Fredholm;Pharmacol. Rev.,2011

2. P1 and P2 purine and pyrimidine receptor ligands;Jacobson,2001

3. Receptors for purines and pyrimidines;Ralevic;Pharmacol. Rev.,1998

4. Recent developments in adenosine receptor ligands and their potential as novel drugs;Müller;Biochimica Biophysica Acta,2011

5. The A3 adenosine receptor: history and perspectives;Borea;Pharmacol. Rev.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3